Insmed ( NASDAQ:INSM – Get Rating ) posted its quarterly earnings results on Thursday. The biopharmaceutical company reported ($1.17) earnings per share for the quarter, missing the consensus estimate of ($1.08) by ($0.09), Briefing.com reports. The business had revenue of $65.20 million during the quarter, compared to analysts' expectations of $63.93 million. Insmed had a negative return on equity of 865.02% and a negative net margin of 196.26%. The business's quarterly revenue was up 22.8% on a year-over-year basis.

https://www.dailypolitical.com/2023/05/05/insmed-nasdaqinsm-releases-quarterly-earnings-results-misses-estimates-by-0-09-eps.html

#dailypolitical